Literature DB >> 33352743

SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy).

Vieri Lastrucci1,2, Chiara Lorini1, Marco Del Riccio3, Eleonora Gori3, Fabrizio Chiesi3, Gino Sartor3, Beatrice Zanella1, Sara Boccalini1, Angela Bechini1, Francesco Puggelli4, Paolo Bonanni1, Guglielmo Bonaccorsi1.   

Abstract

Serosurveys may help to assess the transmission dynamics in high-risk groups. The aim of the study was to assess the SARS-CoV-2 antibody seroprevalence in people who had performed essential activities during the lock-down period in the Province of Prato (Italy), and to evaluate the risk of exposure to SARS-CoV-2 according to the type of service. All the workers and volunteers of the Civil Protection, employees of the municipalities, and all the staff of the Health Authority of the Province of Prato were invited to be tested with a rapid serological test. A total of 4656 participants were tested. SARS-CoV-2 antibodies were found in 138 (2.96%) cases. The seroprevalence in health care workers, in participants involved in essential support services and in those who worked from home were 4.1%, 1.4% and 1.0%, respectively. Health care workers experienced higher odds of seropositivity (OR 4.38, 95%CI 2.19-10.41) than participants who were assigned to work-from-home; no significant seropositivity differences were observed between support services and work-from-home groups. A low circulation of SARS-CoV-2 was observed among participants performing different essential activities. Findings highlighted the risk of in-hospital transmission in healthcare workers and that community support services may increase the risk of seropositivity to a limited extent in low incidence areas.

Entities:  

Keywords:  COVID-19; Italy; SARS-CoV-2; essential activities; healthcare workers; seroprevalence; serosurvey

Year:  2020        PMID: 33352743      PMCID: PMC7766502          DOI: 10.3390/vaccines8040778

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  11 in total

Review 1.  SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.

Authors:  Mobin Azami; Yousef Moradi; Asra Moradkhani; Abbas Aghaei
Journal:  Eur J Med Res       Date:  2022-06-02       Impact factor: 4.981

2.  Validation of the COVID-19 Digital Health Literacy Instrument in the Italian Language: A Cross-Sectional Study of Italian University Students.

Authors:  Chiara Lorini; Veronica Velasco; Guglielmo Bonaccorsi; Kevin Dadaczynski; Orkan Okan; Patrizio Zanobini; Luca P Vecchio
Journal:  Int J Environ Res Public Health       Date:  2022-05-20       Impact factor: 4.614

3.  Predictors of Influenza Vaccination Uptake and the Role of Health Literacy among Health and Social Care Volunteers in the Province of Prato (Italy).

Authors:  Chiara Lorini; Vieri Lastrucci; Beatrice Zanella; Eleonora Gori; Fabrizio Chiesi; Angela Bechini; Sara Boccalini; Marco Del Riccio; Andrea Moscadelli; Francesco Puggelli; Renzo Berti; Paolo Bonanni; Guglielmo Bonaccorsi
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

4.  Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study.

Authors:  Federico Cappellacci; Giacomo Anedda; Stefano Del Giacco; Ferdinando Coghe; Riccardo Cappai; Gian Luigi Canu; Enrico Erdas; Pietro Giorgio Calò; Fabio Medas; Davide Firinu
Journal:  Ann Med Surg (Lond)       Date:  2021-05-04

5.  The indirect impact of COVID-19 pandemic on the utilization of the emergency medical services during the first pandemic wave: A system-wide study of Tuscany Region, Italy.

Authors:  Vieri Lastrucci; Francesca Collini; Silvia Forni; Sara D'Arienzo; Valeria Di Fabrizio; Primo Buscemi; Chiara Lorini; Fabrizio Gemmi; Guglielmo Bonaccorsi
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

6.  Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.

Authors:  Khitam Muhsen; Mitchell J Schwaber; Jihad Bishara; Eias Kassem; Alaa Atamna; Wasef Na'amnih; Sophy Goren; Anya Bialik; Jameel Mohsen; Yona Zaide; Nimrod Hazan; Ortal Ariel-Cohen; Regev Cohen; Pnina Shitrit; Dror Marchaim; Shmuel Benenson; Debby Ben-David; Bina Rubinovitch; Tamar Gotessman; Amir Nutman; Yonit Wiener-Well; Yasmin Maor; Yehuda Carmeli; Dani Cohen
Journal:  Front Med (Lausanne)       Date:  2021-06-24

7.  The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in older people: a region-wide population-based study in Tuscany, Italy.

Authors:  Vieri Lastrucci; Guglielmo Bonaccorsi; Silvia Forni; Sara D'Arienzo; Letizia Bachini; Sonia Paoli; Chiara Lorini; Fabrizio Gemmi
Journal:  Int J Infect Dis       Date:  2021-07-01       Impact factor: 3.623

8.  Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland.

Authors:  Bartosz Szmyd; Filip Franciszek Karuga; Adrian Bartoszek; Katarzyna Staniecka; Natalia Siwecka; Agnieszka Bartoszek; Maciej Błaszczyk; Maciej Radek
Journal:  Vaccines (Basel)       Date:  2021-03-04

9.  Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy.

Authors:  Immacolata Polvere; Alfredina Parrella; Giovanna Casamassa; Silvia D'Andrea; Annamaria Tizzano; Gaetano Cardinale; Serena Voccola; Piercarmine Porcaro; Romania Stilo; Pasquale Vito; Tiziana Zotti
Journal:  Diagnostics (Basel)       Date:  2021-03-09

10.  The Role of Health Literacy in COVID-19 Preventive Behaviors and Infection Risk Perception: Evidence from a Population-Based Sample of Essential Frontline Workers during the Lockdown in the Province of Prato (Tuscany, Italy).

Authors:  Vieri Lastrucci; Chiara Lorini; Marco Del Riccio; Eleonora Gori; Fabrizio Chiesi; Andrea Moscadelli; Beatrice Zanella; Sara Boccalini; Angela Bechini; Francesco Puggelli; Renzo Berti; Paolo Bonanni; Guglielmo Bonaccorsi
Journal:  Int J Environ Res Public Health       Date:  2021-12-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.